AstraZeneca

  • Durham, NC, USA
Full time
 
AstraZeneca Gaithersburg, MD, USA
Opportunity : Global Clinical Development Medical Director Business Unit: Vaccines and Immune Therapies Locations : Gothenburg (Sweden)/Gaithersburg or Durham (US)/ Barcelona (Spain) Salary : Competitive, with excellent benefits Do you have expertise in, and passion for clinical drug development? Are you looking to work at the cutting-edge, where scientific innovations and an entrepreneurial spirit are the norm? We are building a team in AstraZeneca dedicated to Vaccines & Immune Therapies and are looking for passionate and motivated physicians with prior clinical development experience in immune therapies. We therefore are interested to hear from you to start exploring your goals, objectives and career development paths for future opportunities. About AstraZeneca AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines for some of the world’s most...

Full time
 
AstraZeneca Gaithersburg, MD, USA
Opportunity : Global Development Scientist – The Vaccines and Immune Therapies Business Area : Vaccines & Immune Therapies Late Development Locations : US: Gaithersburg/Durham, Sweden: Gothenburg, Spain: Barcelona Salary : Competitive, with excellent benefits Do you have expertise in, and passion for clinical drug development? Are you looking to work at the cutting-edge, where scientific innovations and an entrepreneurial spirit are the norm? Join the team at the heart of AstraZeneca dedicated to Vaccines & Immune Therapies, committed to following the science. About AstraZeneca AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines for some of the world’s most serious diseases. We are more than one of the world’s leading pharmaceutical companies. The Vaccines and Immune Therapies (V&I unit) has been created to optimize AstraZeneca’s portfolio...